0.6980
-0.0780
(-10.05%)
At close: January 30 at 5:29:37 PM GMT+1
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Cash Flow
-7,370.2330
-7,146.2630
-7,481.0310
-7,151.2960
-7,435.4550
Investing Cash Flow
-529.5200
-518.2060
-125.0000
-100.0000
-300.0000
Financing Cash Flow
10,054.4850
10,054.4850
10,319.0880
--
6,253.8800
End Cash Position
11,434.9750
13,103.4830
10,713.4670
8,000.4090
15,251.7050
Capital Expenditure
-529.5200
-518.2060
-125.0000
-100.0000
-300.0000
Issuance of Capital Stock
13,037.1950
13,037.1950
13,272.0160
--
6,864.0000
Free Cash Flow
-7,899.7530
-7,664.4690
-7,606.0310
-7,251.2960
-7,735.4550
6/30/2021 - 5/4/2015
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BIOVIT.ST Bio Vitos Pharma AB (publ)
0.1370
+1.48%
SPEC.ST SpectraCure AB (publ)
2.0150
-7.57%
QLIFE.ST Qlife Holding AB (publ)
2.1400
-2.73%
QLINEA.ST Q-linea AB (publ)
0.3115
-2.81%
SERA Sera Prognostics, Inc.
6.65
+5.72%
XVIVO.ST Xvivo Perfusion AB (publ)
470.00
+2.62%
WOK WORK Medical Technology Group LTD
2.3100
-6.85%
HSCS HeartSciences Inc.
3.3000
0.00%
OWLT Owlet, Inc.
4.6000
+2.00%
CRGT Cortigent, Inc.
0.0000